NCT02722005 The Impact of Family Financial Support on Health Related Quality of Life Status COMPLETED Phase NA
NCT02710032 TransPrEP: Social Network-Based PrEP Adherence for Transgender Women in Peru Status COMPLETED Phase NA
NCT02708940 Participatory Messaging in the UCLA Psychiatry Partial Hospitalization and Intensive Outpatient Programs Status COMPLETED Phase NA
NCT02702453 True NTH Sexual Recovery Intervention for Prostate Cancer Survivors and Their Partners Status COMPLETED Phase NA
NCT02701387 Effect of Implant Thread Design on Implant Stability Quotient (ISQ) in Early Healing Period Status COMPLETED Phase NA
NCT02700425 His Bundle Pacing Versus Coronary Sinus Pacing for Cardiac Resynchronization Therapy Status COMPLETED Phase NA
NCT02699814 H3: Healthy Minds, Healthy Children, Healthy Chicago Project Evaluation Status COMPLETED Phase NA
NCT02698163 Nanodiamond Modified Gutta Percha (NDGP) Composite for Non-surgical Root Canal Therapy (RCT) Filler Material Status COMPLETED Phase NA
NCT02693730 Phenotyping IBS: Perceptions and Modulations of Visceral Sensations Status COMPLETED Phase N/A
NCT02690103 Response Modifier (Arabinoxylan Rice Bran/MGN-3/Biobran) With Interferon-Alpha for HCV Status COMPLETED Phase PHASE2
NCT02687633 Early Behavioral Intervention to Improve Social Communication Function in Infants With Tuberous Sclerosis Complex Status COMPLETED Phase NA
NCT02685605 Intraoperative Radiotherapy in Newly Diagnosed Glioblastoma Multiforme Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT02684565 Effects of Branch Chain Amino Acids on Glucose Tolerance in Obese Pre-Diabetic Subjects Status COMPLETED Phase NA
NCT02679625 Comparison of Non-Invasive Methods of Assessing Fluid Responsiveness in ED and ICU Patients Status COMPLETED Phase N/A
NCT02677909 Computer-Aided, Non-Invasive, Acoustic Gastrointestinal Surveillance (AGIS) in ICU Patients Status WITHDRAWN Phase N/A
NCT02675959 Myeloablative Conditioning, Prophylactic Defibrotide and Haplo AlloSCT for Patients With Sickle Cell Disease Status RECRUITING Phase PHASE2
NCT02658279 Pembrolizumab (MK-3475) in Patients With Recurrent Malignant Glioma With a Hypermutator Phenotype Status ACTIVE_NOT_RECRUITING Phase NA